MEDIFAST INC with ticker code (MED) have now 2 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 278 and 150 calculating the mean target price we have 214. With the stocks previous close at 109.37 this would imply there is a potential upside of 95.7%. The 50 day moving average now sits at 136.57 and the 200 moving average now moves to 173.25. The company has a market capitalisation of $1,244m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,434m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) have now 2 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 278 and 150 with a mean TP of 214. Given that the stocks previous close was at 124.56 this now indicates there is a potential upside of 71.8%. The 50 day MA is 150.07 and the 200 day MA is 178.13. The market cap for the company is $1,331m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,287m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
If you’re looking for dividend stocks to buy and hold forever, a good place to start is companies that have done an excellent job increasing their dividends and are expected to keep doing so in the future. While the first place to look for such names should logically be a list of S&P 500 Dividend Aristocrats, I widened the search to the S&P 1500 . That way, I had three times more stocks to choose from, giving me a much better chance of finding special dividend stocks that deliver income and capital appreciation. From Dec. 31, 1999, to Dec. 31, 2018, the average S&P 1500 stock had a dividend yield of 1.8% . All of the stocks included in this column have yields that meet or exceed that level. In addition, all of the companies have solid balance sheets. To make things even more interesting, I’ll select only the stocks of companies whose net debt is less than $5 billion. I’m confident that, after five years, these dividend stocks to buy and hold forever will be very profitable for investors who purchase them now.
→ Google ترجمة
Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE: MED ). What''s Happening The company announced on Thursday that it would pay shareholders a quarterly dividend of $1.64 per share. On Monday, Medifast will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will … Full story available on Benzinga.com
→ Google ترجمة
Medifast is a consistently profitable growth company. Learn more about MED stock using Chuck Akre''s 3-legged stool investment framework.
→ Google ترجمة
Medifast (NYSE:MED) declares $1.64/share quarterly dividend, in line with previous.Forward yield 5.48%Payable Nov. 8; for shareholders of record Sept. 20; ex-div Sept.
→ Google ترجمة
MEDIFAST INC found using ticker (MED) now have 2 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 278 and 150 and has a mean target at 214. Now with the previous closing price of 119.28 this is indicating there is a potential upside of 79.4%. The day 50 moving average is 156.23 and the 200 day moving average is 180.54. The company has a market capitalisation of $1,314m. Company Website: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,357m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 2 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 278 and 150 with the average target price sitting at 214. Given that the stocks previous close was at 127.13 this indicates there is a potential upside of 68.3%. The day 50 moving average is 160.13 and the 200 moving average now moves to 182.19. The company has a market capitalisation of $1,383m. Visit the company website at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,327m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 2 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 278 and 150 and has a mean target at 214. Now with the previous closing price of 131.54 this is indicating there is a potential upside of 62.7%. There is a 50 day moving average of 164.85 and the 200 moving average now moves to 184.53. The company has a market cap of $1,426m. Visit the company website at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,321m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
A balanced portfolio should have stocks that provide returns in all market conditions. I review three companies - Ares, Medifast And Zscaler. Read more here.
→ Google ترجمة
Jeffrey J Brown , Director at Medifast (NYSE: MED ), reported a large insider buy on August 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Brown purchased 3,940 shares of Medifast. The total transaction amounted to $498,549. Medifast shares are trading up 2.82% at $135.74 at the time of this writing on Friday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an investing … Full story available on Benzinga.com
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 3 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 285 and 150 calculating the average target price we see 237.67. Given that the stocks previous close was at 126 this would indicate that there is a potential upside of 88.6%. There is a 50 day moving average of 174.34 and the 200 moving average now moves to 188.06. The company has a market capitalisation of $1,416m. Company Website: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,671m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
Medifast (MED) stock slumped 16.1% to $144.05 in Thursday trading, as investors overlooked the weight management company''s Q2 earnings beat and focused on its significantly lowered…
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 352 and 285 with the average target price sitting at 327.33. Now with the previous closing price of 174.69 this is indicating there is a potential upside of 87.4%. The day 50 moving average is 177.34 and the 200 moving average now moves to 189.64. The market capitalisation for the company is $1,976m. Visit the company website at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,702m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
https://www.investing.com/news/pro/jefferies-downgrades-medifast-to-hold-432SI-2862879
→ Google ترجمة
Medifast press release (MED): Q2 Non-GAAP EPS of $3.87 beats by $0.64.Revenue of $453.3M (+15.0% Y/Y) beats by $5.43M.The company expects full-year 2022 revenue to be in the range…
→ Google ترجمة
BALTIMORE, Aug. 3, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Compared to the Prior-Year Period…
→ Google ترجمة
Medifast (MED) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, after market close.The consensus EPS Estimate is $3.23 and the consensus Revenue Estimate is…
→ Google ترجمة
BALTIMORE, July 20, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2022 on Wednesday, August 3, 2022, after market close. The…
→ Google ترجمة
MEDIFAST INC found using ticker (MED) have now 3 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 352 and 285 with the average target price sitting at 327.33. With the stocks previous close at 175.58 this indicates there is a potential upside of 86.4%. The 50 day moving average now sits at 178.09 and the 200 moving average now moves to 191.27. The market capitalisation for the company is $2,008m. Find out more information at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,743m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) have now 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 352 and 285 calculating the average target price we see 327.33. Given that the stocks previous close was at 187.67 this is indicating there is a potential upside of 74.4%. The 50 day MA is 178.47 and the 200 day MA is 192.1. The market cap for the company is $2,161m. Find out more information at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,769m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
MEDIFAST INC found using ticker (MED) now have 3 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 352 and 285 with a mean TP of 327.33. Now with the previous closing price of 187.15 this now indicates there is a potential upside of 74.9%. There is a 50 day moving average of 178.7 and the 200 moving average now moves to 192.79. The company has a market capitalisation of $2,106m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,684m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
With Medifast, you get a company that is growing while being profitable, debt-free, paying a generous dividend, and buying back shares. Read more here.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 352 and 285 calculating the mean target price we have 327.33. Now with the previous closing price of 189.17 this now indicates there is a potential upside of 73.0%. The 50 day moving average now sits at 178.63 and the 200 day moving average is 193.04. The company has a market capitalisation of $2,155m. Visit the company website at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,729m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
Medifast, Inc. is a fast-growing company that continues to generate increasing profits and excellent returns for investors. See the real value of MED here.
→ Google ترجمة
Medifast is expanding locally, with the recent opening of a new distribution center in Harford County and a new innovation center in Owings Mills that will focus on research and development.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) now have 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 345 and 300 and has a mean target at 328.67. Now with the previous closing price of 179.17 this would imply there is a potential upside of 83.4%. The day 50 moving average is 178.3 and the 200 day moving average is 194.27. The company has a market cap of $2,076m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,809m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
BALTIMORE, June 15, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer, will meet…
→ Google ترجمة
MEDIFAST INC found using ticker (MED) now have 3 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 352 and 285 with the average target price sitting at 327.33. Now with the previous closing price of 189.47 this would imply there is a potential upside of 72.8%. The 50 day moving average now sits at 177.37 and the 200 moving average now moves to 196.12. The company has a market capitalisation of $2,182m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets="MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $3,769m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.
→ Google ترجمة
Worldwide Market Reports published a new version of the Weight Control Market Research Report in the year 2021 which provides forecast data until 2027. This report offers detailed insights on the global Weight Control market focusing insights on its different
→ Google ترجمة
Advance Market Analytics published a new research publication on Weight Loss Services Market Insights, to 2026 with 232 pages and enriched with self-explained Tables and charts in presentable format. In []
→ Google ترجمة
PALM BEACH, Fla. , July 1, 2021 /PRNewswire/ -- Astaxanthin may be the most important, potent supplements that most people don''t even know exists. Astaxanthin is a powerful, naturally occurring carotenoid pigment that''s found in certain marine plants and animals. It is this that causes the pink or red color in salmon, lobster, trout and seafood. Often called "the king of the carotenoids," Astaxanthin is recognized as being one of the most powerful antioxidants found in nature. Antioxidants are essential for helping combat free radical and oxidative damage to help support a healthy aging process and boost immunity. People take Astaxanthin because of its valuable antioxidant properties. Astaxanthin is 800x stronger than CoQ10, 6,000x stronger than Vitamin C, and 100x stronger than Vitamin E when it comes to antioxidant activity. Astaxanthin helps improve cellular function, and has been linked to improving healthy blood flow, hypertension, improved cardiovascular health, immune health, joint pain, eye health, cognitive alertness and muscle recovery from exercise.
→ Google ترجمة
Stocks Analysis by Zacks Investment Research covering: General Mills Inc, Amazon.com Inc, Netflix Inc, MEDIFAST INC. Read Zacks Investment Research''s latest article on Investing.com
→ Google ترجمة
Related Stocks: MED ,
→ Google ترجمة
Related Stocks: MED ,
→ Google ترجمة
MEDIFAST INC found using ticker (MED) have now 3 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 395 and 295 calculating the average target price we see 346.67. With the stocks previous close at 282.18 this would indicate that there is a potential upside of 22.9%. The 50 day MA is 288.9 and the 200 moving average now moves to 243.51. The company has a market capitalisation of $3,207m. Find out more information at: /> [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
Related Stocks: MED ,
→ Google ترجمة
BALTIMORE , June 11, 2021 /PRNewswire/ -- Medifast (NYSE: MED ), the global company behind one the fastest-growing health and wellness communities, OPTAVIA ®, today released findings from a nationally-representative study on consumer health priorities and motivators. In an earlier survey from December 2020 *, the company found 63% of Americans had adopted new, positive health routines amid the pandemic, 96% of whom planned to continue embracing healthy habits in the new year. Six months into 2021, this new study, which surveyed 1,230 U.S. adults, found that almost all U.S. adults (93%) have health and wellness goals and 84% are actively working toward achieving them . Health Goals: Many of the goals respondents rated as being important to them focus on improving physical health, including wanting to fuel their body with a more healthy, balanced diet (87%) and exercising regularly (85%). 86% of U.S. adults say focusing on mindfulness and their mental health is an important goal for them.
→ Google ترجمة
DGAP-News: MediClin AG / Key word(s): Personnel MediClin AG: Dr. Joachim Ramming becomes the new CEO of MEDICLIN 11.06.2021 / 12:41 The issuer is solely responsible for the content of this announcement. Dr. Joachim Ramming becomes the new CEO of MEDICLIN In today''s meeting, the Supervisory
→ Google ترجمة
Market-thumping sales growth is holding up through early 2021.
→ Google ترجمة
Medifast, Inc., the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced that its Board of Directors has declared a $1.42 quarterly cash dividend to its stockholders.
→ Google ترجمة
DUBLIN , May 28, 2021 /PRNewswire/ -- The "Global Nutrition and Weight Management Products Market: Size, Trends and Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com''s offering. This report provides an in depth analysis of the global weight management market by value, by type of products, etc. The report provides a detailed analysis of the nutrition and weight management products market by value, by health related products, by region, etc. The report also provides a regional analysis of the nutrition and weight management products market, including the following regions: The US, Japan and ROW. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global nutrition and weight management products market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
→ Google ترجمة
DGAP-News: MediClin AG / Key word(s): AGM/EGM MEDICLIN focuses on patient safety and innovative concepts in rehabilitation 28.05.2021 / 09:26 The issuer is solely responsible for the content of this announcement. MEDICLIN focuses on patient safety and innovative concepts in rehabilitation At
→ Google ترجمة
Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Global Nutrition and Weight Management Products Market: Size, Trends and Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com''s offering.
→ Google ترجمة
MEDIFAST INC with ticker code (MED) have now 4 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 400 and 295 calculating the mean target price we have 360. Given that the stocks previous close was at 324.64 this would imply there is a potential upside of 10.9%. The day 50 moving average is 256.5 and the 200 day MA is 230.17. The company has a market capitalisation of $3,887m. Find out more information at: /> [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
Medifast Inc (MED) shares closed today at 1.9% below its 52 week high of $330.77, giving the company a market cap of $3B. The stock is currently up 67.9% year-to-date, up 267.8% over the past 12 months, and up 979.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.3%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 24.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -759.7% The company's stock price performance over the past 12 months beats the peer average by -1508.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 488.9% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
→ Google ترجمة
Medgold Resources Corp (TSX-V: MED.VN) shares dropped -16.67% to end trading Thursday at $0.05 per share - a net change of $-0.01. Shares traded between $0.05 and $0.05 throughout the day. 30000 shares of Medgold Resources Corp exchanged hands. Visit Medgold Resources Corps profile for more information. About The TMX Group TMX Group operates the Toronto Stock Exchange (TSX) and the TSX Venture Exchange, in addition to other derivatives and commodities exchanges. The TSX and TSX Venture Exchange together form the 10th largest stock exchange in the world with over 3,500 listed companies. To get more information on Medgold Resources Corp and to follow the companys latest updates, you can visit the companys profile page here: Medgold Resources Corps Profile . For more news on the financial markets be sure to visit Equities News . Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week. Sources: Chart is provided by TradingView based on 15-minute-delayed prices.
→ Google ترجمة
MEDIFAST INC found using ticker (MED) have now 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 310 and 295 and has a mean target at 301.75. Now with the previous closing price of 317.14 this would indicate that there is a downside of -4.9%. The day 50 moving average is 245.28 and the 200 moving average now moves to 204.69. The market cap for the company is $3,729m. Find out more information at: /> [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
→ Google ترجمة
Medifast Inc (MED) shares closed today at 0.8% below its 52 week high of $296.50, giving the company a market cap of $3B. The stock is currently up 50.8% year-to-date, up 234.0% over the past 12 months, and up 884.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 77.8% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -390.3% The company's stock price performance over the past 12 months beats the peer average by -1067.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 481.5% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
→ Google ترجمة
Jefferies Stick to Their Buy Rating for Medifast Inc
→ Google ترجمة
- ← Previous
- 1
- 2
- Next →